ライフサイエンスコーパス: gram

1 vs. 3.6 +/- 0.4 percentage injected dose per gram).

2 n of liposomes (percent of injected dose per gram).

3 n (+/-SD) concentration of 16.0+/-3.9 mg per gram.

4 Soil had >120000 mean MPN E. coli per gram.

5 25.7 [1.2] weeks and birth weight 813 [183] grams), 184 (24%) underwent ligation.

6 G mimic, as well as PG isolated from various Gram (+) and Gram (-) bacterial species.

7 umor uptake (10 percentage injected dose per gram) and retention and a greater than 5-fold decrease i

8 vs. 2.7 +/- 1.6 percentage injected dose per gram at 3 and 69 h after injection, respectively).

9 119.7 +/- 37.4 percentage injected dose per gram at 3 d after injection.

10 /- 6.0, and >35 percentage injected dose per gram at 4 h after injection, respectively), clearing fro

11 city of less than 0.5 square centimetres per gram, at a velocity of 0.2 +/- 0.1 times light speed.

12 (PatB) catalyzes the O-acetylation of PG in Gram (-) bacteria, which aids in bacterial survival, as

13 blood of asthmatic children with additional Gram + bacteria in the nasopharynx (Gr+/-).

14 ell as PG isolated from various Gram (+) and Gram (-) bacterial species.

15 ons (21 of 19 303) and 0.6% of infants <1000 grams birth weight.

16 ake reached 4.2 percentage injected dose per gram by 20 min.

17 07-2027 by 1.3 to 2.6% (0.6-1.1 billion mega-grams carbon-dioxide-equivalent (Mg CO2e(-1)) compared t

18 Gram for gram, MOFs can absorb as much energy as a high

19 h (36.8 +/- 7.8 percentage injected dose per gram [%ID/g]), whereas uptake in MKN45 xenografts (HGF-n

20 ranged from 1.5 percentage injected dose per gram in noninflamed joints to 22.6 percentage injected d

21 joints to 22.6 percentage injected dose per gram in severely inflamed joints.

22 coa beans to 6mg epicatechin equivalents per gram in the final chocolate.

23 se, and known coronary artery disease), each gram increase of posterior left atrial adipose tissue wa

24 ls learned several syntactic, lexical, and n-gram linguistic biomarkers to distinguish the probable A

25 Gram for gram, MOFs can absorb as much energy as a high explosive

26 Antibacterial activity against model Gram negative and Gram positive bacteria is reported for

27 microbial susceptibility in a wider range of Gram negative and Gram positive bacteria.

28 um chemotaxis towards live gram positive and gram negative bacteria and demonstrate high sensitivity

29 s on the cell wall of both gram positive and gram negative bacteria.

30 imics the structural moieties of its natural Gram negative bacterial pathogen-associated molecular pa

31 he preferential selectivity of the method is gram negative pathogenic species E. coli O157:H7.

32 hyllococcus aureus and Enterococcus) and two gram negative pathogens (E. coli and Salmonella).

33 of broad-spectrum compounds transcending the Gram negative-positive borderline.

34 CD/linalool-IC-NFs inhibited growth of model Gram-negative (E. coli) and Gram-positive (S. aureus) ba

35 Two gram-negative anaerobic rod taxa, Prevotella and Porphyr

36 00 cells per run in a synthetic community of Gram-negative and Gram-positive bacteria and fungi.

37 et, the difference in mechanism of action on gram-negative and gram-positive bacteria may be less pro

38 ed on four bacterial strains, including both Gram-negative and Gram-positive bacteria, showing great

39 re associated with secretion systems in many Gram-negative and Gram-positive bacteria.

40 ce characteristics for the identification of Gram-negative bacilli commonly isolated from blood cultu

41 peptides may therefore be useful in fighting gram-negative bacilli threats through sensitization to e

42 A total of 210 Bactec bottles demonstrating Gram-negative bacilli were prospectively enrolled for th

43 ., Northfield, IL) for the identification of Gram-negative bacilli.

44 Gram-negative bacteremia (GNB) is a major cause of illne

45 Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; beta-lactamas

46 es for the prevention of multidrug-resistant gram-negative bacteria (MDR-GNB) in adult intensive care

47 occus aureus and Streptococcus pyogenes) and gram-negative bacteria (Pseudomonas aeruginosa and Esche

48 urpose, we chose the pilus protein FimG from Gram-negative bacteria and a disulfide-bonded variant of

49 le to rapidly traverse the outer membrane of Gram-negative bacteria and accumulate inside these cells

50 acteria that are obligate predators of other Gram-negative bacteria and are considered potential alte

51 he periplasmic side of the inner membrane of Gram-negative bacteria and are then extracted by the Lpt

52 ed protein H-NS is a key global regulator in Gram-negative bacteria and is believed to be a crucial p

53 lass of molecules found in Gram-positive and Gram-negative bacteria and most archaea(1-5).

54 The hallmark of gram-negative bacteria and organelles such as mitochondr

55 ericidal protein that limits contact between Gram-negative bacteria and the colonic epithelial surfac

56 Although a number of Gram-negative bacteria are known to catabolize quinate a

57 ling and export of amyloid protein sequences.Gram-negative bacteria assemble biofilms from amyloid fi

58 Mouse and human RELMbeta selectively killed Gram-negative bacteria by forming size-selective pores t

59 Bioinformatic screens reveal that these gram-negative bacteria carry genes coding for thiol-disu

60 evalence of MCRPE infection from isolates of Gram-negative bacteria collected at the hospitals from 2

61 nder a low light dose (0.6 J cm(-2) ) toward Gram-negative bacteria E. coli, making it a remarkably e

62 s and Enterococcus faecalis, and against the Gram-negative bacteria Escherichia coli, Escherichia col

63 bat multidrug resistant bacteria, especially Gram-negative bacteria for which the situation is partic

64 Multidrug-resistant (MDR) gram-negative bacteria have increased the prevalence of

65 an effective permeability barrier that makes Gram-negative bacteria inherently resistant to many anti

66 eactivity to antigens from Gram-positive and Gram-negative bacteria is common in patients suffering f

67 Antimicrobial resistance in pathogenic gram-negative bacteria is one of the most pressing chall

68 Activation of TLR4 by Gram-negative bacteria or lipopolysaccharide accelerates

69 lex (Bcc) are a group of multidrug-resistant gram-negative bacteria rarely reported in patients witho

70 Gram-negative bacteria remodel their surfaces to interac

71 ctivity against a panel of Gram-positive and Gram-negative bacteria revealed structure-activity relat

72 Gram-negative bacteria secrete proteins using a type III

73 represent a major mechanism of resistance in Gram-negative bacteria showing multi-drug or extensively

74 Gram-negative bacteria such as Escherichia coli are prot

75 Lipopolysaccharide (LPS) is the component of Gram-negative bacteria that activates Toll-like receptor

76 Brucella spp. are facultative intracellular Gram-negative bacteria that cause the zoonotic disease b

77 imeric channels across the outer membrane of Gram-negative bacteria that mediate the import or export

78 complexes constitute a primary mechanism for Gram-negative bacteria to expel toxic molecules for surv

79 and utilization of enterobactin permits many Gram-negative bacteria to thrive in environments where l

80 acter baumannii is one of the most difficult Gram-negative bacteria to treat and eradicate.

81 an discriminate between viable and nonviable Gram-negative bacteria to tune the immune response, ther

82 Many pathogenic Gram-negative bacteria use the type III secretion system

83 Many Gram-negative bacteria use type 2 secretion systems (T2S

84 omysalin is active against Gram-positive and Gram-negative bacteria using a microdilution assay.

85 Colonization by resistant gram-negative bacteria was significantly associated with

86 sceptibility profiles of clinically relevant Gram-negative bacteria within two hours of antibiotic in

87 The cell envelope of gram-negative bacteria, a structure comprising an outer

88 enable gene exchange between five species of Gram-negative bacteria, and that the identity of the gen

89 In Gram-negative bacteria, efflux pumps are able to prevent

90 HFM and showed that HFM increases rat fecal Gram-negative bacteria, elevates lipopolysaccharides (LP

91 espread antibiotic resistance, especially of Gram-negative bacteria, has become a severe concern for

92 id development of resistance particularly in Gram-negative bacteria, illustrates the urgent need for

93 In many Gram-negative bacteria, including Rhodobacter capsulatus

94 The zauPzapA operon is present in diverse Gram-negative bacteria, indicating a common mechanism fo

95 In Gram-negative bacteria, lipid modification of proteins i

96 multitude of essential cellular functions in Gram-negative bacteria, mitochondria and chloroplasts.

97 ride (LPS), which is a membrane component of gram-negative bacteria, secrete more EVs than cholangioc

98 In Gram-negative bacteria, some of these pumps form multi-p

99 light that, although BAM is conserved across Gram-negative bacteria, structural and functional differ

100 In many Gram-negative bacteria, the peptidoglycan synthase PBP1A

101 le for detecting lipopolysaccharide (LPS) of Gram-negative bacteria, was immobilized on both a large

102 ted excellent sensitivity to trace levels of Gram-negative bacteria, while remaining insensitive to b

103 otein in the extracellular matrix of enteric Gram-negative bacteria.

104 eta-barrel outer membrane proteins (OMPs) in Gram-negative bacteria.

105 rel proteins into the outer membrane (OM) of Gram-negative bacteria.

106 e role of Type Vd secreted phospholipases in Gram-negative bacteria.

107 tic cell-cell interactions between competing Gram-negative bacteria.

108 t clinical needs in treating infections with Gram-negative bacteria.

109 are also relevant for other T3SS-containing Gram-negative bacteria.

110 domains are widespread in toxins that target Gram-negative bacteria.

111 sidues that occurs in most Gram-positive and Gram-negative bacteria.

112 anders are multifaceted infections caused by gram-negative bacteria.

113 mbrane has long defined the cell envelope of Gram-negative bacteria.

114 with the virulence of medically significant Gram-negative bacteria.

115 fections caused by multidrug-resistant (MDR) Gram-negative bacteria.

116 iaminopimelic-type peptidoglycans present in Gram-negative bacteria.

117 t commensal and pathogenic Gram-positive and Gram-negative bacteria.

118 her MDR pathogens, such as malaria, HIV, and Gram-negative bacteria.

119 upies the space between the two membranes of Gram-negative bacteria.

120 purposing candidate to treat infections with Gram-negative bacteria.

121 Gram-negative bacterial endotoxin lipopolysaccharide (LP

122 nflammasome-based surveillance machinery for Gram-negative bacterial infections has been recently dis

123 In Drosophila the Imd pathway detects Gram-negative bacterial infections through recognition o

124 The Gram-negative bacterial outer membrane (OM) is a unique

125 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen associated with acute a

126 locks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing metabolic cell wall

127 ibility profiling for both Gram-positive and Gram-negative bacterial species requires at least 48-72

128 e III and type IV effector proteins from six Gram-negative bacterial species to interact with the euk

129 ncludes well-characterized gram-positive and gram-negative bacterial strains published by ARLG invest

130 needle-tip invasin proteins SipD and IpaD of Gram-negative bacterial type-3 secretion systems that br

131 The Gram-negative bacterium Bordetella pertussis is the caus

132 de to understand morphology in the dimorphic Gram-negative bacterium Caulobacter crescentus.

133 ions with model biological membranes and the Gram-negative bacterium Shewanella oneidensis MR-1.

134 This method was successfully applied to a Gram-negative bacterium; it has yet to be implemented in

135 Aggregatibacter actinomycetemcomitans is a Gram-negative commensal bacterium of the oral cavity whi

136 The mission of the Gram-Negative Committee is to advance our knowledge of t

137 nce with previously identified DSDs from the Gram-negative genus, Acinetobacter, but instead shows li

138 of antimicrobial resistance, particularly in Gram-negative hospital pathogens, which has led to renew

139 TTOT (48.21 versus 11.75 h; P < 0.001), the Gram-negative infection (GNI) TTOT (71.83 versus 35.98 h

140 cal development for the treatment of serious Gram-negative infections.

141 pment of novel therapeutic options to manage Gram-negative infections.

142 The outer membrane (OM) of Gram-negative is a unique lipid bilayer containing LPS i

143 Here, we have addressed this question in the Gram-negative model bacterium Burkholderia thailandensis

144 Twenty-one small Gram-negative motile coccobacilli were isolated from 15

145 f the Burkholderia cepacia complex (Bcc) are Gram-negative opportunisitic bacteria that are capable o

146 is a potent phospholipase A2 secreted by the Gram-negative opportunistic pathogen, Pseudomonas aerugi

147 Emerging evidence also indicates that gram-negative oral bacteria, such as Porphyromonas gingi

148 Pseudomonas aeruginosa is a pathogenic gram-negative organism that has the ability to cause bli

149 ms predominate, whereas later more resistant Gram-negative organisms are found.

150 Among neonates, Gram-negative organisms were the predominant cause of ea

151 The nefarious Gram-negative pathogen Pseudomonas aeruginosa encodes el

152 icle considers the cases of the non-invasive Gram-negative pathogen Vibrio cholerae and the invasive

153 CDI systems are distributed widely among Gram-negative pathogens and are thought to mediate inter

154 vel E3 ligase (NEL) domain that is unique to Gram-negative pathogens and whose activity is repressed

155 Numerous Gram-negative pathogens infect eukaryotes and use the ty

156 ype II secretion (T2S) is one means by which Gram-negative pathogens secrete proteins into the extrac

157 bapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible car

158 d apparatus functions in the injectisomes of gram-negative pathogens to export virulence factors into

159 rio bacteriovorus bacteria naturally prey on Gram-negative pathogens, including antibiotic-resistant

160 cterial activity, including activity against Gram-negative pathogens.

161 class of molecules toward difficult-to-treat Gram-negative pathogens.

162 e- and multidrug-resistant Gram-positive and Gram-negative pathogens.

163 beta-lactam activity in a broad range of MDR Gram-negative pathogens.

164 inst a diverse panel of multi-drug-resistant Gram-negative pathogens.

165 g ventilator-associated pneumonia) caused by Gram-negative pathogens.

166 only associated with antimicrobial-resistant Gram-negative pathogens.

167 LyeTxI/betaCD was determined for planktonic Gram-negative periodontopathogens.

168 ival of microbiota members from the dominant Gram-negative phylum Bacteroidetes depends on their abil

169 g, modifying and finally destroying walls of Gram-negative prey bacteria, modifying their own PG as t

170 lipopolysaccharide, a cell wall component of Gram-negative Proteobacteria and known inducer of lupus

171 eriovorus and Micavibrio aeruginosavorus are Gram-negative proteobacteria that are obligate predators

172 ons: gram-positive Staphylococcus aureus and gram-negative Pseudomonas aeruginosa (99.3 +/- 1.9% and

173 ic Gram-positive rods and other uncultivable Gram-negative rods, and, rarely, opportunistic microorga

174 at recurrent nonlethal gastric infections of Gram-negative Salmonella enterica Typhimurium (ST), a ma

175 NAs in monocytes isolated from patients with Gram-negative sepsis compared with healthy control subje

176 endent Ags, and they are more susceptible to Gram-negative sepsis.

177 e a number of clinical isolates of important Gram-negative species-Enterobacter cloacae, Escherichia

178 multidrug resistant (MDR) Gram-positive and Gram-negative species.

179 s composed of 15 conserved proteins in model gram-negative species.

180 13 showed moderate activity against the MDR Gram-negative strains, with MICs in the range of 16-32 m

181 al NADases predicted to transit not only the Gram-negative T6SS but also the Gram-positive type VII s

182 Six gram-negative waterborne pathogens were used to demonstr

183 Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen that infects immun

184 dingly from 25mg epicatechin equivalents per gram non-fat dry matter in raw fresh cocoa beans to 4mg/

185 reased from 30mg epicatechin equivalents per gram non-fat dry matter in raw fresh cocoa beans to 6mg

186 moles of rcSso7d-CBD was found to adsorb per gram of cellulose, yielding a volume-averaged binder con

187 etrieval from a density of 215 petabytes per gram of DNA, orders of magnitude higher than previous re

188 99g)Tc was found to be 1.5 x 10(9) atoms per gram of dried sample material, demonstrating the sensiti

189 of 32mg of anthocyanins were quantified per gram of dry extract.

190 tors ranged from 6 x 10(8) to 6 x 10(11) per gram of printed part, depending on the type of filament

191 and 18.8 percentage of injected activity per gram of tissue (%IA/g), respectively, for the antagonist

192 acer injection (percentage injected dose per gram of tissue: 1.92 +/- 0.43 vs. 0.90 +/- 0.17; P = 0.0

193 Providing kilocalories per kilogram or grams of protein per kilogram early post-ALI diagnosis a

194 as the CV (i.e., SD divided by the mean) of grams of protein per meal.

195 that this strategy, which provides access to grams of tNMPs, hundreds of milligrams of 2-MeImptNs, an

196 to the energy density (ED) (kilocalories per gram) of foods, but few studies have examined the brain

197 Mean uptake (percentage injected dose per gram) of the dual-labeled tracer in tumors was 17.2 +/-

198 approximately 30.6 petagrams (30.6 x 10(15) grams) of carbon belowground (95 per cent confidence int

199 Mean amount of alcohol consumed was 82.59 grams over the evening.

200 production for NPs from mg level to 10 s of grams per batch, with the potential for continuous manuf

201 mate the association between protein intake (grams per day) and BMD, ALM, appendicular lean mass norm

202 s mean outcomes across quartiles of protein (grams per day) and protein food clusters.The mean +/- SD

203 were similar for early but not late protein (grams per kilogram) exposure (early-exposure HR: 8.9, 95

204 ned in terms of mean ethanol consumption (in grams) per day.

205 of the conjugate was determined against two gram positive (Staphyllococcus aureus and Enterococcus)

206 tified Dictyostelium chemotaxis towards live gram positive and gram negative bacteria and demonstrate

207 ith cis-diol groups on the cell wall of both gram positive and gram negative bacteria.

208 ial activity against model Gram negative and Gram positive bacteria is reported for selected compound

209 Its antibacterial activity is limited to gram positive bacteria.

210 bility in a wider range of Gram negative and Gram positive bacteria.

211 In recent years gram-positive (G(+)) bacteria, most commonly staphylococ

212 growth of model Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria to a great extent.

213 d to successfully monitor the growth of both gram-positive (Staphylococcus aureus and Streptococcus p

214 ns are a diverse class of molecules found in Gram-positive and Gram-negative bacteria and most archae

215 IgE reactivity to antigens from Gram-positive and Gram-negative bacteria is common in pa

216 of antibacterial activity against a panel of Gram-positive and Gram-negative bacteria revealed struct

217 emonstrate that promysalin is active against Gram-positive and Gram-negative bacteria using a microdi

218 ation of MurNAc residues that occurs in most Gram-positive and Gram-negative bacteria.

219 iviridae can infect commensal and pathogenic Gram-positive and Gram-negative bacteria.

220 f these building blocks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing m

221 cation and susceptibility profiling for both Gram-positive and Gram-negative bacterial species requir

222 strain catalogue includes well-characterized gram-positive and gram-negative bacterial strains publis

223 els of tetracycline- and multidrug-resistant Gram-positive and Gram-negative pathogens.

224 l activity against multidrug resistant (MDR) Gram-positive and Gram-negative species.

225 acteria, while remaining insensitive to both Gram-positive and viral challenges.

226 The highest ranked Gram-positive bacteria (high priority) were vancomycin-r

227 the formation of competence-induced pili in Gram-positive bacteria and corroborate the remarkable st

228 n a synthetic community of Gram-negative and Gram-positive bacteria and fungi.

229 uld be used for the quantitative analysis of Gram-positive bacteria and might be applied potentially

230 However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells posse

231 ver, treated cattle had reduced abundance of gram-positive bacteria at the genus level.

232 al functions of specific compounds, and that Gram-positive bacteria considered to be obligate aerobes

233 The cell wall of Gram-positive bacteria contains abundant surface-exposed

234 ased on self-assembly of vancomycin (Van) on Gram-positive bacteria for imaging bacterial infection.

235 in mechanism of action on gram-negative and gram-positive bacteria may be less pronounced than forme

236 Gram-positive bacteria were responsible for a high propo

237 In Gram-positive bacteria, CPS linkage is to either the cyt

238 t activity and antibacterial effects against Gram-positive bacteria, namely methicillin-susceptible S

239 basis for formation of the 100S complexes in Gram-positive bacteria, shedding light on the mechanism

240 al strains, including both Gram-negative and Gram-positive bacteria, showing great potential for appl

241 Pheromones of many gram-positive bacteria, such as Bacillus and Streptococc

242 In other gram-positive bacteria, such as Enterococcus faecalis, d

243 ss regulator Spx is ubiquitously found among Gram-positive bacteria.

244 omplementing the method's proven utility for Gram-positive bacteria.

245 secretion systems in many Gram-negative and Gram-positive bacteria.

246 tial target for evaluating antimicrobials in gram-positive bacteria.

247 protein family, which is spread widely among gram-positive bacteria; and suggests approaches to targe

248 polymers are omnipresent constituents of the Gram-positive bacterial cell wall where they fulfill a v

249 pposed to protective, role for IL-17A during Gram-positive bacterial infections.

250 ococcus aureus and Streptococcus pneumoniae, Gram-positive bacterial pathogens of significant clinica

251 ogous pore-forming proteins secreted by many Gram-positive bacterial pathogens.

252 ids as a positive determinant of size in the Gram-positive bacterium Bacillus subtilis and the single

253 lethanolamine halve during elongation of the Gram-positive bacterium Listeria innocua.

254 The mission of the Gram-Positive Committee of the Antibacterial Resistance

255 TTOT (75.17 versus 43.06 h; P < 0.001), the Gram-positive contaminant TTOT (48.21 versus 11.75 h; P

256 first physiological barrier breached by the Gram-positive facultative pathogen Listeria monocytogene

257 None of the gram-positive isolates were vancomycin resistant.

258 coli dnaK mutants, rather than those in the Gram-positive model organism Bacillus subtilis.

259 postburn hospitalization, more susceptible, Gram-positive organisms predominate, whereas later more

260 natural product that is active only against Gram-positive organisms, into an antibiotic with activit

261 The Gram-positive pathogen Staphylococcus aureus uses one pr

262 The cause might be allergic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent

263 phylococcus aureus, a metabolically flexible gram-positive pathogen, causes infections in a variety o

264 Approved ARLG projects involving gram-positive pathogens include (1) a pharmacokinetics/p

265 By contrast, more than 92.0% of common Gram-positive pathogens remain susceptible to either pen

266 For many gram-positive pathogens, conjugative plasmid transfer is

267 nes encoding fibronectin-binding proteins of Gram-positive pathogens.

268 nisms, uncultivable asaccharolytic anaerobic Gram-positive rods and other uncultivable Gram-negative

269 esponsible for hospital acquired infections: gram-positive Staphylococcus aureus and gram-negative Ps

270 not only the Gram-negative T6SS but also the Gram-positive type VII secretion system, a pathway recen

271 powerful cryptand hosts readily available in gram quantities in good yields from methyl 4(or 3)-hydro

272 o major natural compounds 7 and 8 with multi-gram quantities.

273 s synthesized were also readily scaled up to gram quantities.

274 ified by performing the reaction sequence on gram scale and also by the synthetic transformations of

275 In addition, through experiments on gram scale in palladium, mechanistically important addit

276 the protocol is demonstrated by performing a gram scale reaction.

277 esize discrete oligomers/macromolecules on a gram scale with molecular weights up to 27.4 kDa (128mer

278 The reaction can be run on a gram scale with reduced catalyst loading without impacti

279 The reactions are scalable to the gram scale, testifying the robustness of the transformat

280 from glucose to DFG was obtained on a multi-gram scale.

281 ng bicyclic adduct in excellent yield at the gram scale.

282 The catalyst is suitable for gram-scale biosynthesis, providing up to 15,300 turnover

283 esicle diameter and polydispersity, allowing gram-scale fabrication of monodisperse polymersomes with

284 is straightforward and efficient, providing gram-scale of cage compounds.

285 Utility is highlighted by gram-scale preparation of representative products throug

286 ly of MC2050, a potent PARP-1 inhibitor; and gram-scale preparations.

287 Short gram-scale syntheses of both enantiomers of 2-amino-3-hy

288 rt reaction time, transition metal-free, and gram-scale synthesis are the advantages of this method.

289 The developed method was applied for gram-scale synthesis of a fluorinated analogue of G prot

290 the utility of our method in the efficient, gram-scale synthesis of key biologically active compound

291 ability of the method is demonstrated by the gram-scale synthesis of the key synthetic precursor of b

292 nctional-group tolerance, and amenability to gram-scale synthesis.

293 Notably, this synthesis is the first gram-scale total synthesis of a guaianolide natural prod

294 ith its extremely low cost (about 3 cent per gram), simplicity of fabrication and environment-friendl

295 d (SACCT) and determined the failure rate of Gram stain smears (GSS) due to insufficient cellular mat

296 are the samples of choice for point-of-care Gram stain testing to diagnose Neisseria gonorrhoeae inf

297 was considered pneumococcal if either sputum Gram stain, sputum culture, blood culture, or the immuno

298 ent infections without organisms detected by Gram staining.

299 week of gestation, with birth weight of 950 grams, who was born in an ambulance by spontaneous vagin

300 decline in birth weight was attenuated (0.37 grams/year).